• Recent news

  • Capital Markets Day 2017

    Biotec Pharmacon ASA ("Biotec", OSE: BIOTEC) announces today the company´s strategic update and 2020 ambitions at Biotec´s Capital Markets Day 2017 (CMD). The company is currently building revenues in 4 different markets with a 2020 revenue ambition of NOK 150-200 million where partnerships and value creating activities will be key priorities. -…

    Continue reading

Latest presentation

Presentation of the second quarter 2017

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 16.4 million (15.3) in the second quarter of 2017, and a negative EBITDA of NOK 4.4 million (-1.6). Woulgan® generated sales of NOK 0.9, up from NOK 0.4 million in the first quarter of 2017 . ArcticZymes continued its positive sales growth…

View more